Prevalence of mutations in inherited retinal diseases: A comparison between the United States and India

Post navigation

Identification of African-Specific Admixture between Modern and Archaic Humans

MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma

Signios Biosciences:
348 Hatch Drive Foster City, CA 94404, USA
Call us: +1 888-440-0954
Email us: info@signiosbio.com

Registered Office:
MedGenome Inc. 108 West 13th Street Wilmington, Delaware 19801, County of New Castle, USA

Stay ahead with exclusive insights, tips, and trends tailored for the multiomics and bioinformatics fields. Subscribe to our newsletter.